Latest Quarterly Financial Results News

Carbonxt has marked a pivotal quarter with the mechanical completion of its Kentucky activated carbon plant, a 14% rise in powdered activated carbon sales, and a successful $1.03 million capital raise, setting the stage for stronger revenue growth in 2025.

Nutritional Growth Solutions reported a slight revenue decline in Q4 FY24 but remains optimistic about growth and profitability in FY25, buoyed by renewed Walmart partnerships and expanding Asian distribution.

Oldfields Holdings Limited reports a robust second quarter for FY2025, highlighting successful strategic realignment and improved financial performance despite ongoing transition costs.

Saferoads Holdings reported a slight revenue dip in Q2 2024 but advanced toward selling its Road Safety Rentals business, while securing approval for a new crash barrier system.

FinTech Chain Limited reports a robust increase in cash balances and positive operating cash flow for Q3 2024, alongside new contract wins and ongoing legal proceedings related to a past misappropriation case.

Bass Oil Limited reported a 27% drop in quarterly revenue amid natural production declines but highlighted promising developments in its Kiwi gas field project in the Cooper Basin.

Freehill Mining has reported a record-breaking December quarter with gross sales doubling to $954,000 and a significant improvement in operating cash flow, positioning the company for sustained growth in 2025.

Noumi Limited’s Q2 FY25 results reveal a resilient plant-based milks segment driving growth, even as traditional dairy and nutritionals face margin pressures amid a challenging market.

TerraCom Limited reported resilient coal sales of 1.6 million tonnes for the December quarter despite weather disruptions, while advancing its Moorlands Thermal Coal Project and maintaining a fully franked dividend.

Jatcorp Limited faces a sharp revenue drop due to a trademark dispute in China but accelerates growth with new Moroka® products and expanded distribution channels.

TZ Limited reported a quarterly revenue shortfall in Q2 FY2025 due to delayed US projects but anticipates a strong rebound post-election and strategic growth through acquisition.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.